We are live on ! Find out more
SFM

Soros Fund Management Portfolio holdings

AUM $9.12B
1-Year Est. Return 30.69%
This Fund
S&P 500
This Quarter Est. Return
+4.4%
1 Year Est. Return
+30.69%
3 Year Est. Return
+70.05%
5 Year Est. Return
+69.93%
10 Year Est. Return
+534.14%
AUM
$6.02B
AUM Growth
-$1.63B
Cap. Flow
-$2.86B
Cap. Flow %
-47.53%
Top 10 Hldgs %
29.65%
Holding
274
New
78
Increased
32
Reduced
34
Closed
81

Top Buys

Rank Stock Value
1
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$81.5M
2
ARMK icon
Aramark
ARMK
+$46.4M
3
WRK
WestRock Company
WRK
+$39.3M
4
OKTA icon
Okta
OKTA
+$39.3M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$38.8M

Top Sells

Rank Stock Value
1
SPLK
Splunk Inc
SPLK
+$241M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$239M
3
NVO
Novo Nordisk
NVO
+$90.1M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$82.4M
5
FEZ icon
State Street SPDR EURO STOXX 50 ETF
FEZ
+$65.7M

Sector Composition

Rank Sector Weight
1 Healthcare 7.64%
2 Industrials 7.12%
3 Financials 5.45%
4 Communication Services 5.11%
5 Consumer Discretionary 4.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPSB icon
151
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.6B
$1.66M 0.03%
55,800
– –
STVN icon
152
Stevanato
STVN
$5.54B
$1.44M 0.02%
+45,000
New +$1.37M
CRGY icon
153
Crescent Energy
CRGY
$3.74B
$1.19M 0.02%
+99,990
New +$1.13M
SYRE icon
154
Spyre Therapeutics
SYRE
$9.12B
$1.14M 0.02%
+30,038
New +$870K
NEE icon
155
NextEra Energy
NEE
$176B
$1.08M 0.02%
+16,904
New +$990K
PRGS icon
156
Progress Software
PRGS
$1.71B
$753K 0.01%
+14,120
New +$775K
SOLV icon
157
Solventum
SOLV
$14.1B
$696K 0.01%
+10,000
New +$749K
MDGL icon
158
Madrigal Pharmaceuticals
MDGL
$11.8B
$538K 0.01%
+2,016
New +$475K
APLS
159
DELISTED
Apellis Pharmaceuticals
APLS
$526K 0.01%
+8,948
New +$570K
ASND icon
160
Ascendis Pharma A/S
ASND
$16.4B
$519K 0.01%
+3,432
New +$490K
XLF icon
161
State Street Financial Select Sector SPDR ETF
XLF
$58.4B
$517K 0.01%
12,270
– –
SRPT icon
162
Sarepta Therapeutics
SRPT
$1.77B
$512K 0.01%
+3,956
New +$485K
BOLD
163
Boundless Bio
BOLD
$63.8M
$285K ﹤0.01%
+20,000
New +$285K
UTHR icon
164
United Therapeutics
UTHR
$22.9B
$242K ﹤0.01%
+1,054
New +$238K
AAPL icon
165
PUT
Apple
AAPL
$4.56T
– –
-275,000
Closed -$52.9M
APTV icon
166
Aptiv
APTV
$9.61B
– –
-58,972
Closed -$5.29M
ARRY icon
167
Array Technologies
ARRY
$809M
– –
-180,000
Closed -$3.02M
AX icon
168
CALL
Axos Financial
AX
$5.78B
– –
-300,000
Closed -$16.4M
BABA icon
169
Alibaba
BABA
$304B
– –
-75,000
Closed -$5.49M
BAM icon
170
CALL
Brookfield Asset Management
BAM
$84.9B
– –
-150,000
Closed -$6.03M
BAM icon
171
Brookfield Asset Management
BAM
$84.9B
– –
-1
Closed -$40
BIRK icon
172
Birkenstock
BIRK
$6.84B
– –
-625,000
Closed -$30.5M
CI icon
173
Cigna
CI
$72.7B
– –
-45,000
Closed -$13.5M
CMPR icon
174
Cimpress
CMPR
$2.34B
– –
-5,000
Closed -$400K
COF icon
175
PUT
Capital One
COF
$135B
– –
-445,000
Closed -$58.3M
5 6
7
8 9

Similar funds

RWP
RWA Wealth Partners Newton, Massachusetts $9.14B AUM 16.57% 1-Year Est. Return
LCAM
London & Capital Asset Management London, United Kingdom $9.18B AUM 25.04% 1-Year Est. Return
VAS
Vestmark Advisory Solutions Wakefield, Massachusetts $9.02B AUM 20.58% 1-Year Est. Return
A
Allianz Munich, Germany $9.02B AUM 28.63% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
AI
Axiom Investors Greenwich, Connecticut $8.99B AUM 44.68% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Soros Fund Management's Q1 2024 Portfolio in Review

As of Q1 2024, Soros Fund Management held 274 positions worth $6.02B, down 21% from $7.65B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Soros Fund Management withdrew a net $2.86B in Q1 2024, closing 81 positions and reducing 34 holdings. Its most notable exit was Splunk Inc, an estimated $241M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 7.6% of assets, up from 5% a quarter earlier, followed by Industrials and Financials.

Against the trend, Soros Fund Management opened a new position in Cerevel Therapeutics Holdings, Inc. Common Stock worth $82M.

  • Soros Fund Management's largest Q1 2024 buy was Cerevel Therapeutics Holdings, Inc. Common Stock: 1,940,201 shares worth $82M.
  • Soros Fund Management added most to Aramark in Q1 2024, an estimated $46.4M increase.
  • Soros Fund Management's biggest Q1 2024 reduction was Novo Nordisk, cutting an estimated $90.1M.
  • Soros Fund Management fully exited Splunk Inc in Q1 2024, selling an estimated $241M.
  • Soros Fund Management's ten largest holdings make up 30% of its $6.02B portfolio in Q1 2024.
  • Soros Fund Management opened 78 new positions and closed 81 in Q1 2024.
  • Soros Fund Management's portfolio value fell 21% quarter-over-quarter to $6.02B.

Based on Soros Fund Management's 13F filing for Q1 2024, filed 15 May 2024.